retatrutide mechanism triple agonist glp-1 gip glucagon 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with type 2 diabetes, a new phase 3 trial shows. is part of an emerging generation Reta clinical trial data &

The importance of change in GLP-1 users' skin and the concerns of dryness, loss of visible firmness, and changes in texture cannot be overstated, says Julius Few, MD, a plastic surgeon who practices in Chicago, Los Angeles, and New York

Triple-Hormone Combination Retatrutide Induces 24% Body body-composition research [PMID: 37405802] Laboratory literature summary: Triple-Hormone Combination Retatrutide Induces 24% Body body-composition research

Elevations confirm peptide activity though correlation with healing outcomes uncertain

Topical formulations are common for surface skin concerns, while supervised injectable or compounded protocols may be considered for broader regenerative goals